Wave Life Sciences Ltd. - PE Ratio
WVE
Price:
$6.16
Market Cap:
$1.19B
Wave Life Sciences Ltd. (WVE) is a clinical-stage genetic medicine firm dedicated to inventing, refining, and manufacturing novel stereopure oligonucleotide therapies. The company utilizes its proprietary PRISM platform for discovery and drug development. These specialized oligonucleotides are designed to interact with ribonucleic acid (RNA) to precisely modulate protein expression within the body. This involves either diminishing the production of disease-causing proteins, restoring the synthesis of functional proteins, or generally adjusting protein levels as needed. The company's pipeline includes several key programs targeting neurological disorders. WVE-004, a C9orf72 molecule, is being...[Read more]
Industry
Biotechnology
IPO Date
2015-11-11
Stock Exchange
NASDAQ
Ticker
WVE
PE Ratio
[-5.87]
ROE
[-56.41%]
Current Ratio
[11.26]
Dividend Yield
[0%]
Enterprise Value
[656.32M]
Dividend History
The PE Ratio as of June 2026 (TTM) for Wave Life Sciences Ltd. (WVE) is -5.87
According to Wave Life Sciences Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -5.87. This represents a change of -39.90% compared to the average of -9.77 of the last 4 quarters.
Wave Life Sciences Ltd. (WVE) Historical PE Ratio (quarterly & annually)
How has WVE PE Ratio performed in the past?
The mean historical PE Ratio of Wave Life Sciences Ltd. over the last ten years is -7.76. The current -5.87 PE Ratio has changed 7.47% with respect to the historical average. Over the past ten years (40 quarters), WVE's PE Ratio was at its highest in in the June 2022 quarter at 427.63. The PE Ratio was at its lowest in in the December 2025 quarter at -14.17.
Average
-7.76
Median
-8.71
Minimum
-17.67
Maximum
-1.33
Wave Life Sciences Ltd. (WVE) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Wave Life Sciences Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 173.88%
Maximum Annual PE Ratio = -1.33
Minimum Annual Increase = -81.79%
Minimum Annual PE Ratio = -17.67
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -14.05 | -20.50% |
| 2024 | -17.67 | 88.96% |
| 2023 | -9.35 | 173.88% |
| 2022 | -3.41 | 156.64% |
| 2021 | -1.33 | -35.42% |
| 2020 | -2.06 | 36.15% |
| 2019 | -1.51 | -81.79% |
| 2018 | -8.31 | -8.87% |
| 2017 | -9.12 | -15.28% |
| 2016 | -10.76 | -39.95% |
Wave Life Sciences Ltd. (WVE) Average PE Ratio
How has WVE PE Ratio performed in the past?
The current PE Ratio of Wave Life Sciences Ltd. (WVE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-13.69
5-year avg
-9.16
10-year avg
-7.76
Wave Life Sciences Ltd. (WVE) PE Ratio vs. Peers
How is WVE’s PE Ratio compared to its peers?
Wave Life Sciences Ltd.’s PE Ratio is less than Precigen, Inc. (-3.76), less than Zenas BioPharma, Inc. (-2.17), less than Upstream Bio, Inc. (-2.15), greater than Enliven Therapeutics, Inc. (-27.50), greater than Spyre Therapeutics, Inc. (-40.52), greater than ORIC Pharmaceuticals, Inc. (-5.90), greater than Terns Pharmaceuticals, Inc. (-51.41), greater than Tourmaline Bio, Inc. (-18.09), less than Intellia Therapeutics, Inc. (-4.43), greater than Amylyx Pharmaceuticals, Inc. (-10.59),
| Company | PE Ratio | Market cap |
|---|---|---|
| -3.76 | $1.45B | |
| -2.17 | $883.04M | |
| -2.15 | $340.12M | |
| -27.50 | $3.15B | |
| -40.52 | $5.34B | |
| -5.90 | $878.86M | |
| -51.41 | $4.77B | |
| -18.09 | $1.23B | |
| -4.43 | $1.76B | |
| -10.59 | $1.30B |
Build a custom stock screener for Wave Life Sciences Ltd. (WVE) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Wave Life Sciences Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Wave Life Sciences Ltd. (WVE) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Wave Life Sciences Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Wave Life Sciences Ltd.'s PE Ratio?
How is the PE Ratio calculated for Wave Life Sciences Ltd. (WVE)?
What is the highest PE Ratio for Wave Life Sciences Ltd. (WVE)?
What is the 3-year average PE Ratio for Wave Life Sciences Ltd. (WVE)?
What is the 5-year average PE Ratio for Wave Life Sciences Ltd. (WVE)?
How does the current PE Ratio for Wave Life Sciences Ltd. (WVE) compare to its historical average?